| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
84,845 |
81,988 |
$1.94M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
56,347 |
56,143 |
$1.21M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18,531 |
18,053 |
$147K |
| 99215 |
Prolong outpt/office vis |
412 |
404 |
$27K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
790 |
783 |
$25K |
| 99205 |
Prolong outpt/office vis |
346 |
346 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,002 |
4,888 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,744 |
5,925 |
$13K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
970 |
948 |
$13K |
| 99051 |
|
42,683 |
41,858 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
1,312 |
1,296 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,452 |
6,433 |
$3K |
| 81003 |
|
9,749 |
9,618 |
$1K |
| 81025 |
|
5,614 |
5,549 |
$1K |
| 93000 |
|
193 |
190 |
$786.43 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
373 |
367 |
$739.75 |
| 87807 |
|
1,117 |
1,102 |
$388.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
283 |
279 |
$345.43 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
400 |
386 |
$332.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
751 |
740 |
$276.57 |
| 73610 |
|
130 |
130 |
$124.70 |
| 73630 |
|
152 |
149 |
$96.40 |
| 69210 |
|
62 |
60 |
$88.23 |
| 73140 |
|
14 |
14 |
$30.86 |
| 73130 |
|
49 |
49 |
$24.89 |
| 73110 |
|
14 |
13 |
$22.63 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
106 |
102 |
$5.61 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
55 |
53 |
$5.44 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
25 |
25 |
$3.52 |
| 99000 |
|
2,140 |
2,078 |
$0.00 |
| 82962 |
|
39 |
39 |
$0.00 |
| A9150 |
Non-prescription drugs |
18 |
18 |
$0.00 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
14 |
14 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
32 |
32 |
$0.00 |
| 73562 |
|
14 |
13 |
$0.00 |